Suggestions
Elizabeth Leshen
Gene Therapy and Rare Disease Business Development at Novartis
Elizabeth Leshen is a prominent figure in the field of gene therapy and rare diseases, currently holding a leadership position at Novartis. Her professional profile includes:
Current Role
Elizabeth Leshen serves as the Head of Safety, Efficiency, Gene Therapy & Rare Disease at Novartis.14 This position places her at the forefront of innovative medical research and development in the pharmaceutical industry.
Professional Background
Previous Positions::
- Director of External Research Strategy at Novartis for five years5
- MBA Intern at Novartis
- Consultant (prior to joining Novartis)
Expertise and Responsibilities
Elizabeth's role involves:
- Overseeing safety and efficiency in gene therapy and rare disease research
- Participating in business development for gene therapy and rare diseases3
- Contributing to external innovation strategies5
Education
Elizabeth holds an MBA from Harvard Business School2, which complements her expertise in the pharmaceutical and biotechnology sectors.
Industry Involvement
She is a frequent speaker at industry events, such as the Gene Therapy for Rare Disorders Summit14, where she shares her insights on gene therapy development and rare disease treatments.
Elizabeth Leshen's LinkedIn profile (username: elizabethleshen) reflects her current position and professional network, with over 500 connections in the industry.2 Her presence on professional platforms and at conferences underscores her significant role in advancing gene therapy and rare disease research at Novartis.
